Umeclidinium Bromide | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Umeclidinium Bromide
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Umeclidinium Bromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 9 USDMF, 1 KDMF, 10 NDC API, 15 Listed Suppliers, $ API Reference Price

24 API Suppliers
9 USDMF
1 KDMF
10 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

67 Drugs in Development

67 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

28 FDF Dossiers, 4 FDA Orange Book, 12 Europe, 9 Canada, 2 Australia, 1 South Africa

28 FDF Dossiers
4 FDA Orange Book
12 Europe
9 Canada
2 Australia
1 South Africa

RELATED EXCIPIENT COMPANIES

2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 DFE Pharma, 9 Kerry, 7 Microlex e.U, 1 Nitika Pharmaceutical Specialities, 2 Pluviaendo, 1 Prachin Chemical, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Sigachi Industries, 1 Silverline Chemicals, 1 Vasa Pharmachem

2 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
2 DFE Pharma
9 Kerry
7 Microlex e.U
1 Nitika Pharmaceutical Specialities
2 Pluviaendo
1 Prachin Chemical
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Sigachi Industries
1 Silverline Chemicals
1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

14 Fillers, Diluents & Binders, 8 Lubricants & Glidants, 7 Granulation, 5 Direct Compression, 2 Co-Processed Excipients, 1 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Parenteral

14 Fillers, Diluents & Binders
8 Lubricants & Glidants
7 Granulation
5 Direct Compression
2 Co-Processed Excipients
1 Emulsifying Agents
1 Thickeners and Stabilizers
1 Parenteral

DIGITAL CONTENT

39 News #PharmaBuzz

39 News #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 11 Regulatory FDF Prices, 26 Annual Reports

3 US Medicaid Prescriptions
11 Regulatory FDF Prices
26 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

39 US Patents, 11 Health Canada Patents

39 US Patents
11 Health Canada Patents

$ API Ref.Price (USD/KG) : 185,189 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

11 All

01 11GlaxoSmithKline Inc.

filter Patent Reset all filters

11 All

01 22417825

02 32458534

03 32564742

04 32781487

filter Product Reset all filters

11 All

01 8FLUTICASONE FUROATE | UMECLIDINIUM BROMIDE | VILANTEROL TRIFENATATE

02 3UMECLIDINIUM BROMIDE | VILANTEROL TRIFENATATE

filter Dosage Reset all filters

11 All

01 11POWDER

filter Exp Date Reset all filters

11 All

01 22021-08-03

02 32022-09-11

03 32025-04-27

04 32030-11-29

Inke Umeclidinium Bromide

Product Main Page

01

GlaxoSmithKline Inc.

UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-27

Date Granted : 2012-01-10

UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : ANORO ELLIPTA

Patent Number : 2564742

Filing Date : 2005-04-27

Strength per Unit : 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2025-04-27

Date Granted : 2012-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GlaxoSmithKline Inc.

UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-09-11

Date Granted : 2011-11-01

UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : ANORO ELLIPTA

Patent Number : 2458534

Filing Date : 2002-09-11

Strength per Unit : 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2022-09-11

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GlaxoSmithKline Inc.

UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-29

Date Granted : 2018-10-16

UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : ANORO ELLIPTA

Patent Number : 2781487

Filing Date : 2010-11-29

Strength per Unit : 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-11-29

Date Granted : 2018-10-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 100 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-09-11

Date Granted : 2011-11-01

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2458534

Filing Date : 2002-09-11

Strength per Unit : 100 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2022-09-11

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-27

Date Granted : 2012-01-10

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2564742

Filing Date : 2005-04-27

Strength per Unit : 100 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2025-04-27

Date Granted : 2012-01-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-11-29

Date Granted : 2018-10-16

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2781487

Filing Date : 2010-11-29

Strength per Unit : 100 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2030-11-29

Date Granted : 2018-10-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2417825

Filing Date : 2001-08-03

Strength per Unit : 200 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2021-08-03

Date Granted : 2008-07-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2022-09-11

Date Granted : 2011-11-01

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2458534

Filing Date : 2002-09-11

Strength per Unit : 200 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2022-09-11

Date Granted : 2011-11-01

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

GlaxoSmithKline Inc.

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Coatings Trends

Not Confirmed

GlaxoSmithKline Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-27

Date Granted : 2012-01-10

FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE, VILANTEROL TRIFENATATE

Brand Name : TRELEGY ELLIPTA

Patent Number : 2564742

Filing Date : 2005-04-27

Strength per Unit : 200 mcg / 62.5 mcg / 25 mcg

Dosage Form : POWDER

Human Or VET : Human

Route of Administration : INHALATION

Patent Expiration Date : 2025-04-27

Date Granted : 2012-01-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!